Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China

Abstract Background The number of patients experiencing re-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is progressively increasing. In this study, we aimed to explore the differences in clinical characteristics between patients with primary infection and those with re...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao-Chao Qiu, Xiao-Qing Lin, Qiang Zhang, Ya-Long Chen, Xiao-Qiao Su, Ming-Ying Zhang, Le-Fei Zhu, Zhi-Ruo Lin, Fang Cheng, Shang-Ren Xie, Ji-Chan Shi, Xian-Gao Jiang
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-025-10509-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825197559020257280
author Chao-Chao Qiu
Xiao-Qing Lin
Qiang Zhang
Ya-Long Chen
Xiao-Qiao Su
Ming-Ying Zhang
Le-Fei Zhu
Zhi-Ruo Lin
Fang Cheng
Shang-Ren Xie
Ji-Chan Shi
Xian-Gao Jiang
author_facet Chao-Chao Qiu
Xiao-Qing Lin
Qiang Zhang
Ya-Long Chen
Xiao-Qiao Su
Ming-Ying Zhang
Le-Fei Zhu
Zhi-Ruo Lin
Fang Cheng
Shang-Ren Xie
Ji-Chan Shi
Xian-Gao Jiang
author_sort Chao-Chao Qiu
collection DOAJ
description Abstract Background The number of patients experiencing re-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is progressively increasing. In this study, we aimed to explore the differences in clinical characteristics between patients with primary infection and those with re-infection of SARS-CoV-2. Methods A retrospective data analysis was conducted involving patients diagnosed with coronavirus disease 2019 between April 1, 2023, and June 20, 2023. The patients were categorized into two groups: the observation group, consisting of individuals re-infected with SARS-CoV-2, and the control group, comprising those with primary SARS-CoV-2 infection. Results A total of 905 (905/1025) patients were included in the study, with 407 in the observation group and 498 in the control group. The top three clinical symptoms in both groups were fever, cough with expectoration, and dizziness with fatigue (p < 0.001). The clinical classification of patients in the observation group primarily consisted of non-severe cases (p < 0.001). The proportion of hospitalized patients was lower in the observation group than in the control group (p < 0.001). The observation group exhibited a shorter clinical symptom recovery time than that did the control group (median, 5 days vs. 7 days, Log rank p<0.001, HR = 1.907(95% CI 1.669–2.178). Conclusions Patients experiencing SARS-CoV-2 re-infection were primarily classified as non-severe cases, with lower proportions of occurrence of severe and rare critical conditions. The severity was milder compared to that in patients with primary SARS-CoV-2 infection.
format Article
id doaj-art-09a29ccccaee44f68470636e71e82c2a
institution Kabale University
issn 1471-2334
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-09a29ccccaee44f68470636e71e82c2a2025-02-09T12:14:50ZengBMCBMC Infectious Diseases1471-23342025-02-012511910.1186/s12879-025-10509-1Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in ChinaChao-Chao Qiu0Xiao-Qing Lin1Qiang Zhang2Ya-Long Chen3Xiao-Qiao Su4Ming-Ying Zhang5Le-Fei Zhu6Zhi-Ruo Lin7Fang Cheng8Shang-Ren Xie9Ji-Chan Shi10Xian-Gao Jiang11Department of Infectious Diseases, Dingli Clinical College of Wenzhou Medical University, Wenzhou Central HospitalDepartment of Infectious Diseases, Dingli Clinical College of Wenzhou Medical University, Wenzhou Central HospitalDepartment of Infectious Diseases, Dingli Clinical College of Wenzhou Medical University, Wenzhou Central HospitalDepartment of Cardiology, Dingli Clinical College of Wenzhou Medical University, Wenzhou Central HospitalDepartment of Infectious Diseases, Dingli Clinical College of Wenzhou Medical University, Wenzhou Central HospitalDepartment of Cardiology, Dingli Clinical College of Wenzhou Medical University, Wenzhou Central HospitalDepartment of Infectious Diseases, Dingli Clinical College of Wenzhou Medical University, Wenzhou Central HospitalDepartment of Infectious Diseases, Dingli Clinical College of Wenzhou Medical University, Wenzhou Central HospitalDepartment of Infectious Diseases, Dingli Clinical College of Wenzhou Medical University, Wenzhou Central HospitalDepartment of Traditional Chinese Medicine, Dingli Clinical College Of Wenzhou Medical University, Wenzhou Central HospitalDepartment of Infectious Diseases, Dingli Clinical College of Wenzhou Medical University, Wenzhou Central HospitalDepartment of Infectious Diseases, Dingli Clinical College of Wenzhou Medical University, Wenzhou Central HospitalAbstract Background The number of patients experiencing re-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is progressively increasing. In this study, we aimed to explore the differences in clinical characteristics between patients with primary infection and those with re-infection of SARS-CoV-2. Methods A retrospective data analysis was conducted involving patients diagnosed with coronavirus disease 2019 between April 1, 2023, and June 20, 2023. The patients were categorized into two groups: the observation group, consisting of individuals re-infected with SARS-CoV-2, and the control group, comprising those with primary SARS-CoV-2 infection. Results A total of 905 (905/1025) patients were included in the study, with 407 in the observation group and 498 in the control group. The top three clinical symptoms in both groups were fever, cough with expectoration, and dizziness with fatigue (p < 0.001). The clinical classification of patients in the observation group primarily consisted of non-severe cases (p < 0.001). The proportion of hospitalized patients was lower in the observation group than in the control group (p < 0.001). The observation group exhibited a shorter clinical symptom recovery time than that did the control group (median, 5 days vs. 7 days, Log rank p<0.001, HR = 1.907(95% CI 1.669–2.178). Conclusions Patients experiencing SARS-CoV-2 re-infection were primarily classified as non-severe cases, with lower proportions of occurrence of severe and rare critical conditions. The severity was milder compared to that in patients with primary SARS-CoV-2 infection.https://doi.org/10.1186/s12879-025-10509-1SARS-CoV-2ReinfectionClinical characteristicsOmicron variant
spellingShingle Chao-Chao Qiu
Xiao-Qing Lin
Qiang Zhang
Ya-Long Chen
Xiao-Qiao Su
Ming-Ying Zhang
Le-Fei Zhu
Zhi-Ruo Lin
Fang Cheng
Shang-Ren Xie
Ji-Chan Shi
Xian-Gao Jiang
Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
BMC Infectious Diseases
SARS-CoV-2
Reinfection
Clinical characteristics
Omicron variant
title Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
title_full Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
title_fullStr Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
title_full_unstemmed Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
title_short Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
title_sort difference of clinical characteristics in patients with reinfection and primary infection variants of sars cov 2 a retrospective study in china
topic SARS-CoV-2
Reinfection
Clinical characteristics
Omicron variant
url https://doi.org/10.1186/s12879-025-10509-1
work_keys_str_mv AT chaochaoqiu differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina
AT xiaoqinglin differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina
AT qiangzhang differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina
AT yalongchen differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina
AT xiaoqiaosu differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina
AT mingyingzhang differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina
AT lefeizhu differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina
AT zhiruolin differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina
AT fangcheng differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina
AT shangrenxie differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina
AT jichanshi differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina
AT xiangaojiang differenceofclinicalcharacteristicsinpatientswithreinfectionandprimaryinfectionvariantsofsarscov2aretrospectivestudyinchina